Nabriva Therapeutics plc (31) | Human Resources (11)

Browse by Subcategory

Recent Contracts

Amended and Restated Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
2021 Inducement Share Incentive Plan (Filed With SEC on March 11, 2021)
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Sender Consulting LLC, dated as of March 9, 2021 (Filed With SEC on March 11, 2021)
Retention Agreement, dated August 5, 2020, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz (Filed With SEC on November 5, 2020)
Amended and Restated Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Robert Crotty, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
Third Amended and Restated Employment Agreement by and between Nabriva Therapeutics US, Inc. and Steven Gelone, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan, dated as of March 10, 2021 (Filed With SEC on March 11, 2021)
Form of Restricted Share Unit Agreement under the 2017 Share Incentive Plan (Share Withholding) (Filed With SEC on March 12, 2020)
2020 Share Incentive Plan (Filed With SEC on March 12, 2020)
Form of Share Option / Cash Settled Share Appreciation Right Agreement under the 2020 Share Incentive Plan (Filed With SEC on March 12, 2020)
Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz, dated as of March 21, 2018 (Filed With SEC on March 12, 2019)